最小 worthwhile 效应作为成人特发性脊柱侧凸患者报告结局指标中 MCID 的潜在替代方案
该研究前瞻性纳入 2017 年 7 月至 2022 年 8 月间接受手术、术后至少 2 年随访的成年特发性脊柱侧凸患者,用效益-伤害权衡法确定 SRS-22r 的最小 worthwhile 效应(SWE),用锚定法确定最小临床重要差异(MCID),并检验达到 SWE 第 50 百分位阈值与术后满意度的关联。
要点
- SRS-22r 总分 SWE50 为 0.4,自我形象维度 SWE50 为 0.8。
- 术后至少 2 年达到或超过总分 SWE50 阈值与满意度显著相关(p < 0.001)。
- SWE 可作为 MCID 的替代方案解读术后至少 2 年的 PROMs。
核心结论
- SWE 可作为 MCID 的有效替代方案,用于解读成年特发性脊柱侧凸患者术后至少 2 年的患者报告结局指标。
研究设计与样本
- 前瞻性招募 2017 年 7 月至 2022 年 8 月间术后至少 2 年测量满意度的患者,共纳入 119 例亚洲参与者(19 例男性、100 例女性),平均年龄 26.5 ± 7.2 岁。
- 术前用 SRS-22r 问卷以效益-伤害权衡法估计 SWE 阈值,用基线 SRS-22r 和术后至少 2 年的 SRS-30(第 24 至 30 题作为锚)以锚定法确定 MCID。
- 进行结构效度评估,检验达到或超过 SWE 第 50 百分位(SWE50)阈值与术后满意度(SRS-22r 两个满意度问题均 ≥4 分)的关联。
主要发现
- SRS-22r 各维度及总分的绝对 SWE50 估计值:自我形象 0.8(IQR 0.6 至 1.2)、功能 0.0(IQR 0.0 至 0.2)、疼痛 0.0(IQR 0.0 至 0.6)、心理健康 0.4(IQR 0.0 至 0.6)、总分 0.4(IQR 0.2 至 0.6)。
- 相应维度及总分的 MCID 阈值分别为 0.7、0.1、0.1、0.3 和 0.3。
- 达到或超过总分绝对 SWE50 阈值与术后至少 2 年满意度显著相关(p < 0.001);自我形象(卡方 11.3;p < 0.001)、功能(卡方 6.3;p = 0.012)和疼痛(卡方 5.7;p = 0.017)维度亦与满意度显著相关。
关键数值与推荐
- SRS-22r 总分绝对 SWE50 为 0.4(IQR 0.2 至 0.6),MCID 为 0.3。
- 自我形象维度绝对 SWE50 为 0.8(IQR 0.6 至 1.2),MCID 为 0.7。
- 功能维度绝对 SWE50 为 0.0(IQR 0.0 至 0.2),MCID 为 0.1。
- 疼痛维度绝对 SWE50 为 0.0(IQR 0.0 至 0.6),MCID 为 0.1。
- 心理健康维度绝对 SWE50 为 0.4(IQR 0.0 至 0.6),MCID 为 0.3。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The smallest worthwhile effect (SWE) enables patients to evaluate the expected value of a treatment by weighing its benefits, risks, and costs. It has emerged as an alternative to the minimal clinically important difference (MCID) for interpreting patient-reported outcome measures (PROMs). The purposes of this study were to determine the SWE estimates and MCID thresholds in patients undergoing surgery for adult idiopathic scoliosis (AdIS) and to verify whether meeting or exceeding the SWE estimates correlates with satisfaction at a minimum of 2 years postoperatively. METHODS: Patients with postoperative satisfaction measured at a minimum of 2 years were prospectively recruited between July 2017 and August 2022. The Scoliosis Research Society-22 revised (SRS-22r) questionnaire was preoperatively administered to estimate the SWE thresholds using the benefit-harm trade-off method. The baseline SRS-22r and the SRS-30 at a minimum of 2 years postoperatively were recorded to determine the MCID estimates using the anchor-based approach, with questions 24 to 30 of the SRS-30 used as anchors. A construct validity assessment was performed to evaluate the association between meeting or exceeding the 50th percentile of the SWE (SWE50) threshold and postoperative satisfaction (defined as a score of ≥4 on both SRS-22r satisfaction questions). Race and ethnicity data were collected from the medical records. RESULTS: A total of 119 Asian participants (19 male and 100 female) with a mean age of 26.5 ± 7.2 years were included. The absolute SWE50 estimates for the SRS-22r were 0.8 (interquartile range [IQR], 0.6 to 1.2) for self-image, 0.0 (IQR, 0.0 to 0.2) for function, 0.0 (IQR, 0.0 to 0.6) for pain, 0.4 (IQR, 0.0 to 0.6) for mental health, and 0.4 (IQR, 0.2 to 0.6) for the total score. The MCID thresholds for the corresponding domains or total score were 0.7, 0.1, 0.1, 0.3, and 0.3, respectively. Achieving or exceeding the absolute SWE50 threshold for the total score (p < 0.001) or the self-image (chi-square, 11.3; p < 0.001), function (chi-square, 6.3; p = 0.012), or pain (chi-square, 5.7; p = 0.017) domain was significantly correlated with postoperative satisfaction at a minimum of 2 years. CONCLUSIONS: The SWE could serve as an effective alternative to the MCID for interpreting PROMs at a minimum of 2 years postoperatively in patients with AdIS. LEVEL OF EVIDENCE: Prognostic Level II . See Instructions for Authors for a complete description of levels of evidence.
引用
- Liu D, Zhao Z, Li G, et al. The Smallest Worthwhile Effect as a Promising Alternative to the MCID in Estimating PROMs for Adult Idiopathic Scoliosis. J Bone Joint Surg Am. 2025. PMID: 40763206. doi:10.2106/JBJS.24.01269
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。